Trending...
- Green Energy Solar Expands with New Offices in Port St. Lucie, West Palm Beach, and Orlando
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
- The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
FAYETTEVILLE, Ark. - OhioPen -- Health Canada has issued a licence on Lineus Medical's flag ship product, SafeBreak® Vascular, for use on all vascular access lines including peripheral IV catheters, peripherally inserted central catheters, central venous catheters, midlines, IV ports, and interosseous vascular access devices on patients two weeks of age and up. This licence makes Lineus Medical the first company in the world to obtain authorization for the use of a break-away device on all vascular access lines and for both pediatric and adult patients in a country.
SafeBreak Vascular is the only breakaway device for IV lines proven to reduce IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. The separated device also causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. It's a win-win-win. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on Ohio Pen
Will Armstrong, COO of Lineus Medical stated, "This has been a year of growth for the company. This past May, SafeBreak received pediatric clearance for peripheral IVs from the US Food and Drug Administration, and now we are licenced on all lines for children and adults in Canada. We look forward to making SafeBreak available to every hospital and the over 38 million people living in Canada."
Vance Clement, CEO of Lineus Medical, stated, "Lineus Medical is the first company to obtain licence in a country on the full array of vascular lines across pediatric to adult aged patients. Not only are we expanding into every clinical setting including, Emergency Medical Services, veterinary care, and acute care hospitals systems, we are expanding internationally. Every patient, no matter where they live in the world, deserves a SafeBreak on their IV line."
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found on the company website: www.lineusmed.com or you can follow the company on Facebook or LinkedIn.
More on Ohio Pen
1. Data on File
MKG-0230 Rev 00
SafeBreak Vascular is the only breakaway device for IV lines proven to reduce IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. The separated device also causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. It's a win-win-win. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on Ohio Pen
- Storytime With Author Chandra Donelson and Deputy Bowers in Beavercreek, Ohio
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- Festo Features Multi-Axis Positioning Systems at Automate
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
Will Armstrong, COO of Lineus Medical stated, "This has been a year of growth for the company. This past May, SafeBreak received pediatric clearance for peripheral IVs from the US Food and Drug Administration, and now we are licenced on all lines for children and adults in Canada. We look forward to making SafeBreak available to every hospital and the over 38 million people living in Canada."
Vance Clement, CEO of Lineus Medical, stated, "Lineus Medical is the first company to obtain licence in a country on the full array of vascular lines across pediatric to adult aged patients. Not only are we expanding into every clinical setting including, Emergency Medical Services, veterinary care, and acute care hospitals systems, we are expanding internationally. Every patient, no matter where they live in the world, deserves a SafeBreak on their IV line."
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found on the company website: www.lineusmed.com or you can follow the company on Facebook or LinkedIn.
More on Ohio Pen
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- KRATON ANNOUNCES DECISION TO EXIT DOVER SITE TO FOCUS ON CORE BUSINESS GROWTH
- Goodyear Completes Sale of Dunlop Brand
1. Data on File
MKG-0230 Rev 00
Source: Lineus Medical
0 Comments
Latest on Ohio Pen
- ProfiSignal 20 Update Provides Significant Features
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- Trailhead Biosystems Secures $20 Million to Drive Innovation and Accelerate Growth
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Cogent Communications Faces Federal Scrutiny Over Fraudulent Acquisition and 22-Year Corporate Cover-Up
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Columbus: Clean and Safe Corridors Initiative Takes Place on Sullivant Avenue
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
- Psychiatry's Legacy of Racism and Coercion Highlighted in Restraint Deaths
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions
- Adsposure Announces Winners of Annual Transit Awards